xigduo xr
astrazeneca do brasil ltda - propilenoglicolato de dapagliflozina monoidratado, cloridrato de metformina - antidiabeticos
kombiglyze xr
bristol-myers squibb farmacÊutica ltda - antidiabeticos
onglyza
bristol-myers squibb farmacÊutica ltda - antidiabeticos
qtern
astrazeneca do brasil ltda - propilenoglicolato de dapagliflozina monoidratado, cloridrato de saxagliptina di-hidratada - antidiabeticos
invokana
janssen-cilag international nv - canagliflozin - diabetes mellitus, tipo 2 - drogas usadas em diabetes - invokana is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:as monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 e 5.
forxiga
astrazeneca do brasil ltda - dapagliflozina - antidiabeticos
edistride
astrazeneca do brasil ltda - dapagliflozina - antidiabeticos
xigduo xr
bristol-myers squibb farmacÊutica ltda - antidiabeticos
dapagliflozina
ems s/a - dapagliflozina - antidiabeticos
dapagle
legrand pharma indÚstria farmacÊutica ltda - dapagliflozina - antidiabeticos